
Addus HomeCare Corporation (ADUS)
$
100.94
-0.41 (-0.41%)
Key metrics
Financial statements
Free cash flow per share
4.9247
Market cap
1.9 Billion
Price to sales ratio
1.3140
Debt to equity
0.1922
Current ratio
1.8028
Income quality
2.1191
Average inventory
0
ROE
0.0924
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Addus HomeCare Corporation, along with its subsidiaries, delivers vital personal care services to elderly individuals, those with chronic illnesses, and disabled persons, as well as individuals at risk of hospitalization or institutionalization across the United States. The company operates through three primary segments: Personal Care, Hospice, and Home Health. The Personal Care segment is dedicated to providing non-medical support with daily activities, including bathing, grooming, oral care, feeding, dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. In the Hospice segment, Addus offers palliative nursing care, social work, spiritual counseling, homemaker assistance, and bereavement counseling for terminally ill patients and their families. Meanwhile, the Home Health segment caters to individuals requiring skilled nursing and therapies such as physical, occupational, and speech therapy during illness or post-hospitalization. The company's payor clients encompass federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals. As of December 31, 2021, Addus served consumers through 206 offices across 22 states. The gross profit stands at $461,874,000.00 highlighting the company's profitability from core operations. The company incurred an income tax expense of $31,535,000.00 indicating its tax obligations. The income before tax ratio is 0.09 reflecting the pre-tax margin. The company recorded a net income of $95,910,000.00 reflecting its profitability. Additionally, the weighted average number of shares outstanding is 18,447,000.00 highlighting the company's shareholder base. The stock is reasonably priced at $111.90 appealing to a broad range of investors. Despite having a low average trading volume of 222,882.00 indicating lower market activity, Addus HomeCare maintains a mid-range market capitalization of $1,869,234,275.00 positioning it as a steady performer. The company is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape. It belongs to the Healthcare sector, driving innovation and growth. This blend of stable operations and strategic market positioning makes Addus HomeCare a notable presence in its field, attracting interest from investors while fulfilling a crucial role in providing care to those in need.
Investing in Addus HomeCare Corporation (ADUS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Addus HomeCare Corporation stock to fluctuate between $88.96 (low) and $124.44 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-03-17, Addus HomeCare Corporation's market cap is $1,869,234,275, based on 18,518,271 outstanding shares.
Compared to Eli Lilly & Co., Addus HomeCare Corporation has a Lower Market-Cap, indicating a difference in performance.
To buy Addus HomeCare Corporation (ADUS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ADUS. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Revenue: $1,422,530,000 | EPS: $5.19 | Growth: 19.86%.
Visit https://addus.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $136.72 (2025-01-22) | All-time low: $68.57 (2022-02-24).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

zacks.com
An aging population and rising AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, OPCH and ADUS stand to benefit.

seekingalpha.com
Addus HomeCare Corporation (ADUS) Q4 2025 Earnings Call Transcript

zacks.com
Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com
Addus HomeCare (ADUS) came out with quarterly earnings of $1.77 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.38 per share a year ago.

businesswire.com
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the fourth quarter and year-ended December 31, 2025, on Monday, February 23, 2026, after the market close. Addus HomeCare will host a conference call on Tuesday, February 24, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather.

zacks.com
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?

zacks.com
Addus HomeCare (ADUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

zacks.com
COR, ADUS and SEM earn bullish analyst support for 2026 as AI adoption, home care demand and facility expansion fuel medical sector growth.

zacks.com
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?

zacks.com
Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.
See all news